Navigation Links
Atrium Medical Receives FDA Approval for its Novel C-QUR Lite(TM) V-Patch and C-QUR Edge(TM) V-Patch
Date:5/8/2008

HUDSON, N.H., May 8 /PRNewswire/ -- Atrium Medical Corporation is pleased to announce it has obtained US FDA 510(K) approval for two new Omega 3 surgical mesh products; C-QUR Edge(TM) V-Patch and C-QUR Lite(TM) V-Patch.

These new products are indicated for use in the surgical repair and reinforcement of soft tissue, including hernia repair -- a common procedure performed more than 700,000 times in the US each year. This novel technology combines Atrium's ProLite Ultra(TM) polypropylene surgical mesh with a proprietary, pharmaceutical grade Omega 3 fatty acid bio-absorbable gel coating. Atrium's discovery of combining an inert thin wall polypropylene mesh with an Omega 3 biological coating in pre-clinical studies has demonstrated a minimization of tissue attachment as well as a significant reduction in both foreign body reaction and inflammation, resulting in a well healed, reinforced repair.

C-QUR Edge(TM) V-Patch and C-QUR Lite(TM) V-Patch are designed to simplify umbilical, epigastric, trocar-site, and other small abdominal wall hernia repairs. C-QUR Edge(TM) V-Patch offers long-term protection from visceral tissue attachment when placed intra-abdominally while the C-QUR Lite(TM) version offers superior handling and healing characteristics for a pre-peritoneal repair.

The use of Atrium's all natural Omega 3 bio-absorbable coating with its advanced lightweight surgical mesh provides today's clinicians with a broad spectrum of options for soft tissue repair. Atrium's C-QUR Edge(TM) V-Patch and C-QUR Lite(TM) V-Patch will be available in a variety of sizes mid-year 2008.

About Atrium

Atrium's vast expertise in medical device technologies for the treatment of cardiovascular disease, hernia and adhesion prevention has brought a number of breakthrough advances in several diversified healthcare markets including interventional cardiology and radiology, chest trauma care and thoracic drainage, vascular surgery, and soft tissue rep
'/>"/>

SOURCE Atrium Medical Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Atrium Innovations Announces Management Changes
2. Atrium Innovations to Hold 2007 Third Quarter Financial Results Conference Call and Webcast on November 8
3. Atrium Announces a Significant Increase in Revenues and Earnings for the Third Quarter of 2007
4. Atrium Innovations to Hold 2007 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast on February 29
5. Atrium Innovations to Hold 2008 First Quarter Financial Results Conference Call and Webcast on May 6
6. Atrium shows a strong financial performance for its first quarter
7. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
8. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
9. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
10. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
11. BioMS Medical announces its intention to renew a normal course issuer bid
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2014)... 2014 Emerging Nuclear Power Countries - ... , Summary , The latest report from GlobalData, Emerging ... Development Analysis to 2030 covers the emerging nuclear market ... comprehensive information on key market players and their global ... various countries across the world has also been estimated. ...
(Date:7/18/2014)... -- The International Wheat Genome Sequencing Consortium (IWGSC) published ... of the bread wheat genome. The chromosome-based draft provides ... the large, complex genome of the world,s most widely ... an invaluable resource to plant science researchers and breeders. ... a set of tools enabling them to rapidly locate ...
(Date:7/18/2014)... Littleton, MA (PRWEB) July 18, 2014 ... Ph.D. to its growing Advisory Board. Dr. Vaught ... science for over 20 years. As one of ... for Biological and Environmental Repositories - in 1999, he ... he is again president-elect. , In 2005, Dr. Vaught ...
(Date:7/17/2014)... MOUNTAIN VIEW, Calif. , July 17, 2014 /PRNewswire-iReach/ ... preclinical research, today announced the addition of David ... interventionalist, and Benigno Mills , a veterinary surgical ... addition, to better serve our clients, we are pleased ... on Twitter , Facebook and ...
Breaking Biology Technology:Emerging Nuclear Power Countries - Market Forecast, Key Companies and Development Analysis, Size, Share, Growth, Trend to 2030 2Emerging Nuclear Power Countries - Market Forecast, Key Companies and Development Analysis, Size, Share, Growth, Trend to 2030 3Genetic Blueprint of Bread Wheat Genome Unveiled 2Genetic Blueprint of Bread Wheat Genome Unveiled 3Dr. Jim Vaught, Ph.D., Former Chief of BBRB, Joins Provia Laboratories as Advisory Board Member 2Dr. Jim Vaught, Ph.D., Former Chief of BBRB, Joins Provia Laboratories as Advisory Board Member 3SURPASS Announces Two Strategic Hires in Silicon Valley Facility and Launch of Social Media Accounts 2SURPASS Announces Two Strategic Hires in Silicon Valley Facility and Launch of Social Media Accounts 3
... Switzerland, May 16 Arpida Ltd.,(SWX: ARPN) today announced ... for review the New Drug Application (NDA) for,intravenous iclaprim ... (cSSSI). Arpida completed the submission of the NDA to,the ... ten month review to,the iclaprim NDA and has established ...
... Million - ... - Gross Profit Up; Net Loss Down -, TUSTIN, ... a vertically integrated specialty pharmaceutical company headquartered,in Tustin, California, with ... subsidiary Jade Pharmaceutical Inc. (JPI),the Company engages in the research, ...
... Principle Reached to Terminate Marketing Agreement with Triax ... on Most Favorable Terms, NAPA, Calif., May 15 ... company engaged in the development,of technologies that target the ... quarter ended March 31, 2008 and an agreement in,principle ...
Cached Biology Technology:Arpida Announces FDA Acceptance of the Iclaprim New Drug Application 2Arpida Announces FDA Acceptance of the Iclaprim New Drug Application 3AMDL Announces First Quarter 2008 Results Posting Sales of $3.58 Million 2AMDL Announces First Quarter 2008 Results Posting Sales of $3.58 Million 3Senetek PLC Reports First Quarter 2008 Financial Results 2Senetek PLC Reports First Quarter 2008 Financial Results 3
(Date:7/21/2014)... cheating in science are among the topics to ... experts in Montreal at the three International Union ... to August 1, 2014. Some 2,000 participants from ... 14th International Congress of Bacteriology and Applied Microbiology, ... Microbiology, and the 16th International Congress of Virology. ...
(Date:7/21/2014)... in areas across Riau province on Sunday, July 20, ... a decline in rainfall. The number of detected ... had been reported one day prior, which had reached ... six regencies and municipalities, most of which were in ... it creates could potentially spread via winds to Malaysia ...
(Date:7/21/2014)... that uses extracts from seeds of Moringa oleifa trees ... 90% to 99%. The hardy trees that are drought ... Asia, and Latin America. , The protocol, which is ... review, is low-cost and efficient, making it especially useful ... who are presently drinking highly turbid and contaminated water. ...
Breaking Biology News(10 mins):Montreal hosts International Union of Microbiology Societies congresses 2
... must address ecological threats, a top international scientific meeting ... the planet,s natural limits in a striking parallel to ... a subprime loan," Dr. Johan Rockstrm of the Stockholm ... risks of both kinds of crises in the future. ...
... a multi-year $1 million sponsored research agreement with ... the maker of Smart Balance buttery spread and ... cholesterol through a patented blend of natural vegetable ... entered into a collaboration and license to develop ...
... 6, 2008, Cambridge, UK ,Discussion of a man,s background, ... and The City episodes in the future, it could ... Risk of developing type 2 diabetes and metabolic ... this background has in turn been influenced by environment and ...
Cached Biology News:Top scientific meeting urges coordinated response to economic and environmental crises 2Brandeis and Smart Balance team up to advance heart-healthy research 2Coping and copulation behavior may help calculate diabetes risk 2
... Conjugated peptides or recombinant proteins are used ... antibodies in 2 rabbits. pre-immune and three ... until the titer reaches 1:4,000 Western blot ... G purification Antibodies are eluted using both ...
... analysis & visualization software. ... multiple samples. Combine Sequest ... increased confidence. Get more ... from your MS/MS experiments.14 ...
TRIzol Reagents are ready-to-use monophasic solutions of phenol and guanidine isothiocyanate suitable for isolating total RNA DNA and proteins (16)....
...
Biology Products: